Oral phenytoin pharmacokinetics during omeprazole therapy
- PMID: 3689634
- PMCID: PMC1386318
- DOI: 10.1111/j.1365-2125.1987.tb03209.x
Oral phenytoin pharmacokinetics during omeprazole therapy
Abstract
1. In a double-blind crossover study 10 healthy males received either placebo or omeprazole (40 mg day-1) for 9 days, a single dose of phenytoin (300 mg) being taken on the seventh day. 2. Omeprazole significantly increased the area under the curve (0 to 72 h) of phenytoin (mean +/- s.e. mean) from 121.6 +/- 14.0 to 151.4 +/- 13.6 micrograms ml-1 h) (P less than 0.01). 3. The peak concentration, and apparent elimination half-life of phenytoin also tended to be increased though not significantly. 4. The omeprazole-phenytoin interaction observed may be clinically important because of the low therapeutic index associated with phenytoin.
Similar articles
-
No influence of pantoprazole on the pharmacokinetics of phenytoin.Int J Clin Pharmacol Ther. 1996 May;34(1 Suppl):S72-5. Int J Clin Pharmacol Ther. 1996. PMID: 8793606 Clinical Trial.
-
Lack of effect of erythromycin on the pharmacokinetics of single oral doses of phenytoin.Br J Clin Pharmacol. 1988 Sep;26(3):330-3. doi: 10.1111/j.1365-2125.1988.tb05285.x. Br J Clin Pharmacol. 1988. PMID: 3179171 Free PMC article. Clinical Trial.
-
Effect of omeprazole on the pharmacokinetics of oral gemifloxacin in healthy volunteers.Chemotherapy. 1999 Nov-Dec;45(6):496-503. doi: 10.1159/000007244. Chemotherapy. 1999. PMID: 10567781 Clinical Trial.
-
Single oral loading dose of phenytoin: a pharmacokinetics study.J Neurol Sci. 1997 Mar 20;147(1):89-92. doi: 10.1016/s0022-510x(96)05314-2. J Neurol Sci. 1997. PMID: 9094065
-
Atovaquone has no effect on the pharmacokinetics of phenytoin in healthy male volunteers.Br J Clin Pharmacol. 1996 Aug;42(2):246-8. doi: 10.1046/j.1365-2125.1996.40518.x. Br J Clin Pharmacol. 1996. PMID: 8864327 Free PMC article. Clinical Trial.
Cited by
-
Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects.Eur J Clin Pharmacol. 1992;42(3):319-24. doi: 10.1007/BF00266355. Eur J Clin Pharmacol. 1992. PMID: 1577051 Clinical Trial.
-
Pharmacokinetic drug interactions with anti-ulcer drugs.Clin Pharmacokinet. 1998 Aug;35(2):135-50. doi: 10.2165/00003088-199835020-00003. Clin Pharmacokinet. 1998. PMID: 9739480 Review.
-
Antiepileptic drugs. A review of clinically significant drug interactions.Drug Saf. 1993 Sep;9(3):156-84. doi: 10.2165/00002018-199309030-00003. Drug Saf. 1993. PMID: 8240723 Review.
-
Pharmacokinetics of proton pump inhibitors in children.Clin Pharmacokinet. 2005;44(5):441-66. doi: 10.2165/00003088-200544050-00001. Clin Pharmacokinet. 2005. PMID: 15871633 Review.
-
Safety of potent gastric acid inhibition.Drugs. 2005;65 Suppl 1:97-104. doi: 10.2165/00003495-200565001-00013. Drugs. 2005. PMID: 16335863 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources